Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunostimulation by retinoic acid.

G Dennert

    Ciba Foundation Symposium
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Retinoids, like retinoic acid (RA), enhance anti-tumor immunity by boosting T killer cell and natural killer (NK) cell activity. This immune stimulation, particularly through increased interleukin-2 (IL-2) production, offers a novel approach to cancer prevention and treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients.

    The Cochrane database of systematic reviews·2006
    Same author

    Extracellular nicotinamide adenine dinucleotide induces t cell apoptosis in vivo and in vitro.

    Journal of immunology (Baltimore, Md. : 1950)·2001
    Same author

    Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver.

    Journal of immunology (Baltimore, Md. : 1950)·2001
    Same author

    NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection.

    Journal of immunology (Baltimore, Md. : 1950)·2000
    Same author

    Eradication of murine mammary adenocarcinoma through HSVtk expression directed by the glucose-starvation inducible grp78 promoter.

    Breast cancer research and treatment·2000
    Same author

    Fas- and tumor necrosis factor receptor 1-dependent but not perforin-dependent pathways cause injury in livers infected with an adenovirus construct in mice.

    Hepatology (Baltimore, Md.)·2000

    Area of Science:

    • Immunology
    • Cancer Research
    • Pharmacology

    Background:

    • Retinoids are known to inhibit tumor growth in various experimental models.
    • The role of immune system components in mediating retinoid's anti-tumor effects requires further elucidation.

    Purpose of the Study:

    • To investigate the evidence supporting the importance of immune effectors in retinoid-mediated tumor inhibition.
    • To explore the impact of retinoic acid (RA) on cell-mediated cytotoxicity and interleukin-2 (IL-2) production.
    • To assess the protective role of RA against leukaemogenesis in a model involving natural killer (NK) cells.

    Main Methods:

    • Mice were injected with retinoic acid (RA) before tumor cell challenge to assess cell-mediated cytotoxicity.
    • The study analyzed the role of T killer cells and the lymphokine interleukin-2 (IL-2) in RA-induced immune responses.

    Related Experiment Videos

  • Leukaemogenesis was studied in irradiated mice, evaluating the protective effects of NK cell reconstitution and RA injection.

    • Main Results:

    • RA injection significantly increased tumor-specific cell-mediated cytotoxicity, primarily mediated by T killer cells.
    • RA enhanced the capacity of splenocytes to produce IL-2, suggesting a role in T cell induction.
    • RA demonstrated protective effects against leukaemogenesis in mice with impaired NK cell activity.

    Conclusions:

    • Retinoic acid (RA) stimulates T cell-mediated anti-tumor immunity, likely by enhancing IL-2 production and promoting T killer cell induction.
    • RA's ability to protect against leukaemogenesis suggests a role in bolstering natural killer (NK) cell function or directly affecting preleukaemic cells.
    • These findings highlight the immunomodulatory potential of retinoids in cancer therapy and prevention.